Market Tracker

01/18 1:08pm ET

Repligen Corp (NASDAQ:RGEN)

29.90
Delayed Data
As of 12:53pm ET
 +0.19 / +0.64%
Today’s Change
20.07
Today|||52-Week Range
34.06
-2.99%
Year-to-Date

Today’s Trading

Previous close29.71
Today’s open29.68
Day’s range29.61 - 30.37
Volume59,686
Average volume (3 months)257,523
Market cap$1.0B
Dividend yield--
Data as of 12:53pm ET, 01/18/2017

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+58.04%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.45%
P/E ratio149.5
Price/Sales11.37
Price/Book7.98

Competitors

 Today’s
change
Today’s
% change
DERMDermira Inc+0.76+2.67%
AIMTAimmune Therapeutics...-0.32-1.64%
LOXOLoxo Oncology Inc+1.63+4.33%
ACORAcorda Therapeutics ...-0.05-0.24%
Data as of 1:08pm ET, 01/18/2017

Financials

Next reporting dateFebruary 23, 2017
EPS forecast (this quarter)$0.07
Annual revenue (last year)$83.5M
Annual profit (last year)$9.3M
Net profit margin11.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts